Therapix’s cannabinoid Tourette drug makes the grade in phase 2

Therapix is developing cannabinoid -based drugs for pain management, traumatic brain injury and obstructive sleep apnea, as well as Tourette syndrome. … Therapix Biosciences reported topline data from a phase 2a study showing that its cannabinoid -based treatment for Tourette syndrome met its … Read More

The post Therapix’s cannabinoid Tourette drug makes the grade in phase 2 appeared first on Dagga Magazine.

…read more

Leave a Reply

Your email address will not be published. Required fields are marked *